“Comparative Study of Olopatadine Hydrochloride 0.1% and Emedastine difumarate 0.05% Comparing their Clinical Efficacy and Adverse Effects in Allergic Conjunctivitis” (2024) Medical Forum Monthly, 26(5). Available at: https://medicalforummonthly.com/index.php/mfm/article/view/2774 (Accessed: 17 November 2025).